| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |